MoneyWorks4Me

Sanjivani Paranteral informs about changes in board composition

24 Mar 2022 Evaluate

Sanjivani Paranteral has informed that at the meeting of the Board of Directors of the Company held on Thursday, March 24, 2022, the following items were noted, considered and approved: Appointment of Monika Amit Singhania (DIN : 07950196) as an Additional Independent Director on the Board of the Company with effect from March 24, 2022 and Appointment of Srivardhan Ashwani Khemka (DIN: 089421 06) as an Additional Director (Non-Executive Promoter) on the Board of the Company with effect from March 24, 2022. The above appointment of Monika Amit Singhania and Srivardhan Ashwani Khemka is subject to approval by shareholders of the Company. Information as required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 is given in the enclosed Annexure.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..